@article{oai:twinkle.repo.nii.ac.jp:00016080,
 author = {小熊, 英俊},
 issue = {5},
 journal = {東京女子医科大学雑誌},
 month = {May},
 note = {Gastric malignant lymphoma is usually treated surgically. Recently, however, chemotherapy has been combined with surgery to improve the prognosis of this disease. However, since there is no established staging classification, evaluation of the outcome of treatment and therapeutic planning are not standardized. In the present study, 69 patients with non-Hodgkin's B-cell lymphoma of the stomach, which accounts for the majority of malignant gastric lymphomas, who underwent surgical resection were reviewed clinicopathologically, the following 3-stage classification is herein proposed to facilitate uniform assessment of therapy and appropriate management planning: Stage I, tumor confined to the stomach without metastasis to the lymph nodes or other organs; Stage II, tumor arising in the stomach with group 1 or 2 lymph node involvement, regardless of the presence of tumor invasion to the adjacent organs, without distant metastasis; and Stage III, tumor arising in the stomach with group 3 or 4 lymph node involvement, or distant metastasis, regardless of the presence of tumor invasion to the adjacent organs.},
 pages = {292--301},
 title = {切除例からみた胃悪性リンパ腫の外科治療と病期分類の検討},
 volume = {66},
 year = {1996}
}